Statin Initiation and Dementia Incidence in a Large Health Care System From 1997 to 2020
This emulated trial provides Class II evidence that statin initiation is not associated with AD/ADRD or AD incidence after the first year of follow-up.
Authors
- M. Maria Glymour (ORCID: https://orcid.org/0000-0001-9644-3081)
- Vidhu Choudhary (ORCID: https://orcid.org/0009-0009-4720-9518)
- Ronald M. Krauss (ORCID: https://orcid.org/0000-0002-4172-6815)
- Akinyemi Oni‐Orisan (ORCID: https://orcid.org/0000-0002-5897-5543)
- Travis J. Meyers (ORCID: https://orcid.org/0000-0001-9186-9745)
- Scott C. Zimmerman (ORCID: https://orcid.org/0000-0002-4431-6520)
- Catherine Schaefer (ORCID: https://orcid.org/0000-0003-2644-055X)
- Minhyuk Choi (ORCID: https://orcid.org/0009-0000-6658-5054)
- Kaitlin N. Swinnerton (ORCID: https://orcid.org/0000-0002-7429-9960)
- Thomas J. Hoffmann (ORCID: https://orcid.org/0000-0001-6893-4449)
- Erin L. Ferguson (ORCID: https://orcid.org/0000-0003-3136-0001)
- Neil Risch (ORCID: https://orcid.org/0000-0002-4126-2061)
- Chen Jiang (ORCID: https://orcid.org/0000-0002-0336-4518)
- Paola Gilsanz (ORCID: https://orcid.org/0000-0002-7635-381X)
- Rachel A. Whitmer (ORCID: https://orcid.org/0009-0006-9511-6138)
Institutions
- Boston University (US)
- Kaiser Permanente (US)
- University of California, San Francisco (US)
- VA Boston Healthcare System (US)
- University of California, Davis (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1212/wnl.0000000000213855
- Citations
- 2
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 4.01